CN102753174A - 可可碱的药物组合及其在治疗中的用途 - Google Patents

可可碱的药物组合及其在治疗中的用途 Download PDF

Info

Publication number
CN102753174A
CN102753174A CN2010800516299A CN201080051629A CN102753174A CN 102753174 A CN102753174 A CN 102753174A CN 2010800516299 A CN2010800516299 A CN 2010800516299A CN 201080051629 A CN201080051629 A CN 201080051629A CN 102753174 A CN102753174 A CN 102753174A
Authority
CN
China
Prior art keywords
theobromine
opium
antitussive
reagent
dextromethorphan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010800516299A
Other languages
English (en)
Chinese (zh)
Inventor
约翰·布鲁
罗宾·马克·班尼斯特尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reyes Leather Co.,Ltd. Ethiopia Lancome
Infirst Healthcare Ltd
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41509324&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN102753174(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of CN102753174A publication Critical patent/CN102753174A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2010800516299A 2009-11-13 2010-11-12 可可碱的药物组合及其在治疗中的用途 Pending CN102753174A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0919889.6A GB0919889D0 (en) 2009-11-13 2009-11-13 Drug composition and its use in therapy
GB0919889.6 2009-11-13
PCT/GB2010/051895 WO2011058373A2 (en) 2009-11-13 2010-11-12 Drug combination with theobromine and its use in therapy

Publications (1)

Publication Number Publication Date
CN102753174A true CN102753174A (zh) 2012-10-24

Family

ID=41509324

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010800516299A Pending CN102753174A (zh) 2009-11-13 2010-11-12 可可碱的药物组合及其在治疗中的用途

Country Status (16)

Country Link
EP (1) EP2498777A2 (ja)
JP (2) JP2013510841A (ja)
CN (1) CN102753174A (ja)
AU (1) AU2010317667B2 (ja)
BR (1) BR112012011227A2 (ja)
CA (1) CA2780703A1 (ja)
CO (1) CO6551744A2 (ja)
GB (1) GB0919889D0 (ja)
IL (1) IL219768A0 (ja)
MX (1) MX2012005532A (ja)
NZ (1) NZ599949A (ja)
PE (1) PE20130147A1 (ja)
RU (1) RU2519086C2 (ja)
UA (1) UA108993C2 (ja)
WO (1) WO2011058373A2 (ja)
ZA (1) ZA201204248B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US20190008850A1 (en) * 2015-12-30 2019-01-10 Paul J. Markovitz Method of treating schizophrenia

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008002514A2 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
KR20000069131A (ko) * 1996-11-25 2000-11-25 데이비드 엠 모이어 알파-2 아드레날린수용체 아고니스트로서 유용한 구아니디닐 헤테로사이클 화합물
HUP9700654A2 (hu) * 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
US20030206942A1 (en) * 1998-09-25 2003-11-06 Neema Kulkarni Fast dissolving orally consumable films containing an antitussive and a mucosa coating agent
US6207674B1 (en) * 1999-12-22 2001-03-27 Richard A. Smith Dextromethorphan and oxidase inhibitor for weaning patients from narcotics and anti-depressants
RU2350316C2 (ru) * 2003-05-29 2009-03-27 Унилевер Нв Композиция для обработки волос
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
WO2008089260A2 (en) * 2007-01-16 2008-07-24 Victory Pharma, Inc. Combined administration of benzonatate and guaifenesin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008002514A2 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PETER V. DICPINIGAITIS ET AL: "Currently available antitussives", 《PULMONARY PHARMACOLOGY & THERAPEUTICS》 *

Also Published As

Publication number Publication date
CO6551744A2 (es) 2012-10-31
NZ599949A (en) 2013-08-30
RU2519086C2 (ru) 2014-06-10
JP6118919B2 (ja) 2017-04-19
AU2010317667B2 (en) 2014-05-29
IL219768A0 (en) 2012-07-31
CA2780703A1 (en) 2011-05-19
AU2010317667A1 (en) 2012-06-07
EP2498777A2 (en) 2012-09-19
BR112012011227A2 (pt) 2017-06-13
MX2012005532A (es) 2012-09-28
PE20130147A1 (es) 2013-03-13
RU2012124038A (ru) 2013-12-20
JP2016128439A (ja) 2016-07-14
JP2013510841A (ja) 2013-03-28
WO2011058373A3 (en) 2011-07-07
ZA201204248B (en) 2013-02-27
WO2011058373A2 (en) 2011-05-19
UA108993C2 (en) 2015-07-10
GB0919889D0 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
CN102753174A (zh) 可可碱的药物组合及其在治疗中的用途
CN102802625A (zh) 可可碱和抗组胺剂的治疗组合物
CN102740853B (zh) 可可碱的药物组合及其在治疗中的用途
CA2784214C (en) Combination of theobromine with a decongestant and its use for the treatment of cough
AU2015201845B2 (en) Drug combination with theobromine and its use in therapy
AU2015200654B2 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
AU2015201844B2 (en) Therapeutic Combinations of Theobromine and an Antihistamine

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: THE FIRST MEDICAL HEALTH CARE CO., LTD.

Free format text: FORMER OWNER: RUISI PIKOU PIYA CO., LTD.

Effective date: 20141210

Owner name: RUISI PIKOU PIYA CO., LTD.

Free format text: FORMER OWNER: BIOCOPEA LTD.

Effective date: 20141210

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20141210

Address after: London, England

Applicant after: InFirst Healthcare Ltd.

Address before: Dublin, Ireland

Applicant before: Reyes Leather Co.,Ltd. Ethiopia Lancome

Effective date of registration: 20141210

Address after: Dublin, Ireland

Applicant after: Reyes Leather Co.,Ltd. Ethiopia Lancome

Address before: London, England

Applicant before: BIOCOPEA Ltd.

RJ01 Rejection of invention patent application after publication

Application publication date: 20121024

RJ01 Rejection of invention patent application after publication